The American Journal of Managed Care

Anlotinib Plus Chemotherapy Shows Promising Results in Advanced Soft Tissue Sarcoma

Anlotinib combined with chemotherapy showed a 30.8% ORR and 82.7% DCR in advanced STS patients, indicating promising efficacy ...
The American Journal of Managed Care

MRI Guideline Adherence Is Lacking in Soft Tissue Sarcoma

Despite such guidelines, though, the investigators said there is a lack of evidence-based or widely accepted consensus on ...

A Bucks Co. toddler will advocate for less toxic treatments as an ambassador for a national cancer charity

Adalyn Hetzel had just celebrated her second birthday in the spring of 2024 when doctors at Children’s Hospital of ...

Faron Expands Bexmarilimab Program in Solid Tumors with a Randomized Phase I/II BEXAR IIT in Metastatic Soft-Tissue Sarcoma

Study conducted in a collaboration between MEDSIR and University Hospital Vall d'Hebron to evaluate bexmarilimab plus standard-of-care doxorubicin in a high-unmet-need frontline setting. TURKU, FI / ...
EurekAlert!

"Glowing molecule" in this first-in-human clinical trial is poised to revolutionize soft-tissue sarcoma surgery, improving cure rates

New research from Dartmouth Health and Dartmouth Cancer Center reveals a glowing molecule designed to highlight soft-tissue sarcomas during surgery, paving the way for more precise tumor removal and ...
CURE

FDA Grants Orphan Drug Designation to LP-284 for Soft Tissue Sarcoma

The FDA's orphan drug designation supports LP-284's development for soft tissue sarcomas, addressing significant unmet needs in this adult patient population. The FDA granted orphan drug designation ...
EWN

Community rallies for Panorama Primary pupil battling rare cancer

Chanterie van Rensburg was recently diagnosed with a rare soft-tissue cancer and needs help to fund her treatment.